ESR1 and breast cancer: A study shows that under the condition of coexpression of ERα and ERβ, HER2 expression is frequently found to be negative, whereas the Ki-67 index is upregulated, indicating an association between this special combination of biomarkers and breast cancer aggressiveness [46].